trending Market Intelligence /marketintelligence/en/news-insights/trending/jOqNiktOxdOVVpApEOj_eA2 content esgSubNav
In This List

Mylan launches generic version of seizure injections

Blog

Gauging Supply Chain Risk In Volatile Times

Blog

Insight Weekly: Banks' efficiency push; vacuuming carbon; Big Pharma diversity goals

Blog

The Future of Risk Management Digitization in Credit Risk Management

Blog

Climate Credit Analytics: Diving into the model


Mylan launches generic version of seizure injections

Mylan NV launched a generic version of Pfizer Inc.'s Cerebyx injection in the U.S.

The fosphenytoin sodium injections will be available in single-use vials for the treatment of certain types of seizures.

The treatment had U.S. sales of approximately $36.3 million for the 12 months ending Oct. 31, according to IMS Health.